Chapter 18* of Title 22 of the District of Columbia Municipal Regulations (DCMR), entitled “Prescription Drug Marketing Costs” requires manufacturers and labelers of prescription drugs dispensed in the District who engage in marketing in the District of Columbia (“District”) to report to the Department of Health (“Department”) their costs for pharmaceutical drug marketing in the District. Those regulations are consistent with Title III of the AccessRx Act of 2004*. Each manufacturer or labeler is required to report their prescription drug marketing costs in an annual report filed with the Department on or before July 1 of each year.
 
 The annual report is to be accompanied by a filing fee in the amount of two thousand five hundred dollars ($2,500). This fee is an annual fee that is to be paid by each manufacturer or labeler who files the required annual report. The filing fee is payable exclusively by check, and checks are to be made payable to the DC Treasurer.

 

Companies that filed annual reports for 2006 should note that the required reporting format has changed. Manufacturers and labelers required to file an annual report for 2007 must use these documents:

The 2007 Prescription Drug Marketing Costs document contains three Excel sheets that the company must fill out: Company Information, Gift Expenses, and Advertising Expenses. Complete instructions for filling out these forms are available in the PDF document and also in the fourth sheet of the Excel document.

 

The Company Information, Gift Expenses, and Advertising Expenses sheets should be filled out completely according to the instructions and submitted electronically to dc.accessrx@dc.gov. In addition, the Company Information sheet should be printed and sent to the Department along with a $2,500 filing fee check made payable to DC Treasurer. Please mail this document and check to:

 

Department of Health
Pharmaceutical Control – AccessRx
ATTN: Helen Y. Saccone, PharmD
717 14th St., NW Suite 600
Washington, DC 20005